Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioXcel Therapeutics (BTAI) Debt Ratio (2022 - 2025)

BioXcel Therapeutics (BTAI) has 4 years of Debt Ratio data on record, last reported at 2.44 in Q3 2025.

  • For Q3 2025, Debt Ratio rose 14.05% year-over-year to 2.44; the TTM value through Sep 2025 reached 2.44, up 14.05%, while the annual FY2024 figure was 2.67, 95.89% up from the prior year.
  • Debt Ratio reached 2.44 in Q3 2025 per BTAI's latest filing, down from 4.21 in the prior quarter.
  • Across five years, Debt Ratio topped out at 4.21 in Q2 2025 and bottomed at 0.0 in Q1 2022.
  • Average Debt Ratio over 4 years is 1.44, with a median of 1.23 recorded in 2024.
  • Peak YoY movement for Debt Ratio: surged 199612.67% in 2023, then grew 14.05% in 2025.
  • A 4-year view of Debt Ratio shows it stood at 0.45 in 2022, then soared by 200.59% to 1.36 in 2023, then surged by 95.89% to 2.67 in 2024, then decreased by 8.88% to 2.44 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 2.44 in Q3 2025, 4.21 in Q2 2025, and 2.74 in Q1 2025.